/EIN News/ — SAN DIEGO, CA, April 20, 2021 (GLOBE NEWSWIRE) — through NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis firm within the United States that launched the world’s first-ever cannabis-derived nutraceutical merchandise, manufacturers and provide chain, introduced immediately that the Company’s CEO Dr. Stuart Titus can be presenting nearly at a cannabis investing convention, the 2021 Sequire Cannabis Conference, on Tuesday, April 20, at 1 p.m. EDT/10 a.m. PDT.
Titus will talk about the Company’s long-running success as a frontrunner within the non-psychoactive cannabinoid business, together with turning into the primary to create a world product pipeline of hemp-based cannabidiol (CBD) merchandise, the primary to legally ship CBD throughout U.S. state traces and the primary firm to obtain historic import permits for CBD merchandise from the governments of Brazil, Mexico, Argentina, and Paraguay. Titus was one of many first main U.S.-based traders within the cannabis business and can share how he intends to proceed main the Company to success because the business evolves.
“The North American cannabis industry has seen tremendous growth in the last year and we are proud to have been one of the first companies to help build the industry into what it has become today,” Titus stated. “Our current growth strategy takes the industry’s great progress into account as we prepare to evolve alongside it and continue filling the ever-changing needs of our consumers.”
The Sequire Cannabis Conference is a one-day occasion that brings collectively a choose group of U.S. traders and main business members within the cannabis house. The occasion will characteristic video shows from greater than 15 firms, organized in 5 tracks for attendees.
For those that can’t attend the reside presentation, a video webcast of the presentation can be out there. To be taught extra in regards to the 2021 Sequire Cannabis Conference and register to take part, go to https://cannabis-conference.mysequire.com.
About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis firm with three distinct enterprise items within the non-psychoactive cannabinoid house: a world portfolio of cannabinoid-based nutraceutical manufacturers led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality authorized non-psychoactive cannabis merchandise derived from industrial hemp; and a cannabinoid-based medical analysis and botanical drug growth sector led by its pharmaceutical funding firms and companions together with AXIM® Biotechnologies, Inc. and Neuropathix, Inc. Medical Marijuana, Inc. was named a prime CBD producer by CNBC. Medical Marijuana, Inc. was additionally the primary firm to obtain historic import permits for CBD merchandise from the governments of Brazil, Mexico, Argentina, and Paraguay and is a frontrunner within the growth of worldwide markets. The firm’s flagship product Real Scientific Hemp Oil has been utilized in a number of profitable medical research all through Mexico and Brazil to know its security and efficacy.
Medical Marijuana, Inc.’s headquarters is in San Diego, California, and extra info is offered at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s company video, click here.
Shareholders and shoppers are additionally inspired to purchase CBD oil and different merchandise at Medical Marijuana, Inc.’s store.
This press launch might comprise sure forward-looking statements and knowledge, as outlined throughout the that means of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is topic to the Safe Harbor created by these sections. This materials incorporates statements about anticipated future occasions and/or monetary outcomes which can be forward-looking in nature and topic to dangers and uncertainties. Such forward-looking statements by definition contain dangers, uncertainties and different components, which can trigger the precise outcomes, efficiency or achievements of Medical Marijuana, Inc. to be materially totally different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements haven’t been evaluated by the Food and Drug Administration. This product shouldn’t be meant to diagnose, deal with, remedy, or stop any illness.
Medical Marijuana, Inc. doesn’t promote or distribute any merchandise which can be in violation of the United States Controlled Substances Act.
Public Relations Contact:
Investor Relations Contact:
P. (858) 283-4016